AMANDA ROTHENBECKER: Open Payments
NPI 1568831329 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 11 payments from 7 companies in 2025. Trend: 2023 $277 · 2024 $190 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Ardelyx, Inc. | 3 | $61 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| Vifor Pharma, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Fresenius USA Marketing, Inc. | 1 | $23 |
Products named: JARDIANCE, IBSRELA, TARPEYO, Veltassa, Kerendia, FARXIGA, VELPHORO.
Industry payments across MD — which companies pay providers there.
